Verona, Italy

Elisabetta De Magistris

This inventor holds 1 USPTO granted patent. Top assignee: Glaxo Wellcome Spa. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elisabetta De Magistris. Retrieved from https://idiyas.com/inventor/elisabetta-de-magistris

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elisabetta De Magistris: Innovator in Pharmaceutical Chemistry

Introduction

Elisabetta De Magistris is a prominent inventor based in Verona, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds. Her work has been recognized for its potential impact on medical science.

Latest Patents

Elisabetta holds a patent for "3-Substituted-indole-2-carboxylic acid derivatives as excitatory amino." This innovative compound showcases her expertise in creating new chemical entities that may have therapeutic applications.

Career Highlights

Elisabetta is currently employed at Glaxo Wellcome Spa, a leading pharmaceutical company. Her role involves research and development, where she applies her knowledge to advance drug discovery and formulation.

Collaborations

Throughout her career, Elisabetta has collaborated with notable colleagues, including Romano Di Fabio and Aldo Feriani. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Elisabetta De Magistris exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions through patents and collaborations continue to shape the future of medical research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…